BridgeBio Pharma shares are trading higher after multiple firms raised their respective price targets on the stock.
Portfolio Pulse from Benzinga Newsdesk
Shares of BridgeBio Pharma are trading higher following price target upgrades from multiple firms.

July 18, 2023 | 4:23 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
BridgeBio Pharma's stock price is expected to increase in the short term due to price target upgrades from multiple firms.
Price target upgrades from multiple firms indicate a positive outlook on the company's stock. This typically leads to increased investor confidence, which can drive up the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100